Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 17,500 | reported | 30 Jan 2014 | tx 1+17,500 |
| Strongbridge Biopharma plc | 0 | reported | 05 Oct 2021 | tx 9+160,000−274,918 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Oct 2021 | OTHER | Strongbridge Biopharma plc | 64,151 | — | |
| 05 Oct 2021 | OTHER | Strongbridge Biopharma plc | 154,918 | — | deriv |
| 01 Oct 2021 | TAX_WITHHOLDING | Strongbridge Biopharma plc | 17,763 | 2.06 USD | |
| 18 May 2021 | GRANT_AWARD | Strongbridge Biopharma plc | 40,000 | 0.00 USD | |
| 14 May 2021 | TAX_WITHHOLDING | Strongbridge Biopharma plc | 19,004 | 2.35 USD | |
| 15 May 2020 | TAX_WITHHOLDING | Strongbridge Biopharma plc | 19,082 | 2.86 USD | |
| 14 May 2020 | GRANT_AWARD | Strongbridge Biopharma plc | 40,000 | 0.00 USD | |
| 15 May 2019 | GRANT_AWARD | Strongbridge Biopharma plc | 40,000 | 0.00 USD | |
| 15 May 2018 | GRANT_AWARD | Strongbridge Biopharma plc | 40,000 | 0.00 USD | deriv |
| 30 Jan 2014 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 17,500 | 0.00 USD | deriv |